NCT00313092

Terminated

Obstructive Sleep Apnea Syndrome in Glaucoma

Selim Orguel Source

Selim Orguel

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

045-LEJ-2004-002

Study Type

observational

Actual enrollment (reported)

60

Locations

1 country

Sites

1

Timeline

Study Start

January 2005

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2005

Actual (reported)

Study Completion

September 2005

Actual (reported)

Brief Summary

The aim of the study is to determine if plasma matrix-metalloproteinase activity can predict glaucoma in patients with OSAS and if the level of plasma matrix-metalloproteinase activity will decrease after one month of nCPAP-treatment.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: terminated
Actual enrollment (reported): 60 participants
Study completion date: September 2005
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2005
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
September 2005
Actual (reported)
Study Completion
September 2005
Actual (reported)
First Submitted
April 10, 2006
Actual (reported)
First Posted
April 11, 2006
Actual (reported)

Last Updated: October 2, 2015
Status Verified: October 2015
Last Update Submitted: October 1, 2015

Conditions

Glaucoma Obstructive Sleep Apnea Syndrome

Keywords

OSASglaucomaMMP

Interventions

nCPAP treatmentDevice

treatment with positive air pressure during night

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 95 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with sleep apnoe syndrom

You may qualify if:

OSAS planned begin of a nCPAP treatment

You may not qualify if:

Sponsors & Collaborators

Selim Orguel
Otherlead
University Hospital, Basel, Switzerland
Othercollaborator

Study Sites (1)

University Hospital Basel, Eye Clinic

Basel, Canton of Basel-City, 4031, Switzerland

Biospecimen

Retention: NONE RETAINED

plasma

MeSH Terms

Conditions

Sleep Apnea, ObstructiveGlaucoma

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesOcular HypertensionEye Diseases

Study Officials

Selim Orgül, MD
University Eye Clinic Basel
STUDY DIRECTOR

Enrollment

60 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Prof. Dr.

Study Record Dates

First Submitted

April 10, 2006

First Posted

April 11, 2006

Study Start

January 2005

Date type not reported

This date has not been verified as actual or estimated.

NCT00304824

Assessment of the Ability to Distinguish Odors in Glaucoma Patients

Completed

NCT00628173

Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma, Superior Versus Inferior

Not ApplicableCompleted

NCT00837018

Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients

Not ApplicableCompleted

NCT00346541

Role of Polymorphisms in the IL-1 Gene Cluster

Completed

NCT00714740

Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude

Phase 4Completed

NCT01780207

Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea

Not ApplicableCompleted

Current malignancy
Oral steroids

Contact the study team to confirm eligibility.

Primary Completion

September 2005

Actual (reported)

Study Completion

September 2005

Actual (reported)

Last Updated

October 2, 2015

Record last verified: 2015-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00313092
Data provider: ClinicalTrials.gov
Source updated: 2015-10-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:31:53 UTC

Locations

CH(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations